Product Information
CLONAZEPAM 1 MG ODT is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.5546 per EA under NDC 00093929367. Its NADAC has been published 217 times since Jun 29, 2022.
FDA first approved this application on Aug 10, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093929367
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077194FDA Approved
8/10/2005
TE Code
AB
On Market Since
11/22/2021
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 1 MG ODT has been published 217 times since Jun 29, 2022, and over the history we have for it it has declined 26.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5546 per EA |
|---|---|
| All-time high | $0.8268 (Nov 16, 2022) |
| All-time low | $0.4241 (Mar 22, 2023) |
| 52-week high | $0.5921 |
| 52-week low | $0.4879 |
| Median price | $0.5862 |
| Average price | $0.5921 |
| Largest weekly change | +48.7% (Jun 19, 2024) |
| Weeks tracked | 217 |
| Tracking since | Jun 29, 2022 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLONAZEPAM 1 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 1 MG ODT, manufactured by Teva Pharmaceuticals USA Inc., is $0.5546 per EA (NDC 00093929367), effective Aug 19, 2026.
How has the price of CLONAZEPAM 1 MG ODT changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 1 MG ODT has declined 26.1%. It has been tracked across 217 weekly CMS publications since Jun 29, 2022.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 1 MG ODT?
Since Jun 29, 2022, the NADAC for CLONAZEPAM 1 MG ODT has ranged from a low of $0.4241 (Mar 22, 2023) to a high of $0.8268 (Nov 16, 2022), with a median of $0.5862 per EA.
Are there cheaper alternatives to CLONAZEPAM 1 MG ODT?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLONAZEPAM 1 MG TABLET, is $0.0245 per EA — about 96% below CLONAZEPAM 1 MG ODT.
Who manufactures CLONAZEPAM 1 MG ODT?
CLONAZEPAM 1 MG ODT (NDC 00093929367) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.